VivoSim Labs, Inc. Treasury Stock, Common, Shares
VivoSim Labs, Inc. (VIVS) had Treasury Stock, Common, Shares of 3 shares as of 2026-03-31, per its 10-K filed 2026-07-14.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure
us-gaap:TreasuryStockCommonShares · last filed 2026-07-14
- 2026-03-31: Treasury Stock, Common, Shares 3.00 shares.
- 2025-12-31: Treasury Stock, Common, Shares 3.00 shares.
- 2025-09-30: Treasury Stock, Common, Shares 3.00 shares.
- 2025-06-30: Treasury Stock, Common, Shares 3.00 shares.
| Period end | Treasury Stock, Common, Shares | Treasury Stock, Common, Shares as first filed |
|---|---|---|
| 2026-03-31 | 3.00 shares 10-K · filed 2026-07-14 | |
| 2025-12-31 | 3.00 shares 10-Q · filed 2026-02-11 | |
| 2025-09-30 | 3.00 shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 3.00 shares 10-Q · filed 2025-08-12 | |
| 2025-03-31 | 3.00 shares 10-K · filed 2026-07-14 | |
| 2024-12-31 | 46.00 shares 10-Q · filed 2025-02-19 | |
| 2024-09-30 | 46.00 shares 10-Q · filed 2024-11-08 | |
| 2024-06-30 | 46.00 shares 10-Q · filed 2024-08-05 | |
| 2024-03-31 | 3.00 shares 10-K · filed 2025-06-05 | 46.00 shares 10-K · filed 2024-05-31 |
| 2023-12-31 | 46.00 shares 10-Q · filed 2024-02-08 | |
| 2023-09-30 | 46.00 shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 46.00 shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | 46.00 shares 10-K · filed 2024-05-31 | |
| 2022-12-31 | 46.00 shares 10-Q · filed 2023-02-09 | |
| 2022-09-30 | 46.00 shares 10-Q · filed 2022-11-10 | |
| 2022-06-30 | 46.00 shares 10-Q · filed 2022-08-11 | |
| 2022-03-31 | 46.00 shares 10-K · filed 2023-07-14 | |
| 2021-12-31 | 46.00 shares 10-Q · filed 2022-02-14 | |
| 2021-09-30 | 46.00 shares 10-Q · filed 2021-11-08 | |
| 2021-06-30 | 46.00 shares 10-Q · filed 2021-08-06 | |
| 2021-03-31 | 46.00 shares 10-K · filed 2022-06-10 | |
| 2020-03-31 | 0.00 shares 10-K · filed 2021-06-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |